Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa

<p>Background: In sub-Saharan Africa, severely immunocompromised HIV-infected individuals have high mortality (10%) from infections shortly after starting antiretroviral therapy (ART). </p><p> Methods: The REALITY factorial open-label trial (ISRCTN43622374) randomized Ugandan/Zimb...

Full description

Bibliographic Details
Main Authors:	Hakim, J, Musiime, V, Szubert, A, Mallewa, J, Siika, A, Agutu, C, Walker, S, Pett, S, Bwakura-Dangarembizi, M, Lugemwa, A, Kaunda, S, Karoney, M, Musoro, G, Kabahenda, S, Nathoo, K, Maitland, K, Griffiths, A, Thomason, M, Kityo, C, Mugyenyi, P, Prendergast, A, Walker, A, Gibb, D
Format:	Journal article
Published:	Massachusetts Medical Society 2017

Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa

Similar Items